Business Wars Daily cover image

The “King Kong” of Weight Loss Drugs May Upend Ozempic

Business Wars Daily

00:00

The Importance of O'Zempic

O'Zempic, an injectable drug made by Novo Nordisk, was approved to treat obesity back in 2021. But now the drug's popularity seems to have exploded thanks in part to Hollywood. A run on O'Zampic has caused many insurance companies to stop covering it for patients unless they have diabetes. The Wall Street Journal calls Eli Lilly's Manjaro "the King Kong of weight loss drugs"

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app